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Abstract
Background: Pancreatic hamartoma is an extremely rare benign disease of the pancreas. Only 30 cases have been
reported to date.
Case presentation: A 68-year-old man presented with an asymptomatic solid and multi-cystic lesion in the uncus
of the pancreas, incidentally detected on abdominal enhanced computed tomography. The tumor was found to be
a well-demarcated solid and multi-cystic lesion without any enhancement, measuring 4 cm in diameter. After
28 months of follow-up, the tumor enlarged. At 31 months after initial diagnosis, the patient underwent surgical
resection because it was difficult to clinically determine whether the tumor was malignant or not. Macroscopically,
the solid tumor consisted of yellow adipose tissue with a smooth thin capsule confined to the pancreatic uncus.
The inner structure of the tumor consisted of multiple cysts with a white nodule between the cysts. Histologically,
the solid part and the multi-cystic portion consisted of mature adipose tissue and colonization of dilated pancreatic
ducts with mild fibrosis, respectively. Immunohistochemical findings revealed cytokeratin 7 and 19 positive staining
in the epithelial cells of the ducts. Adipose tissue showed positive staining for S-100 protein and there were only a
few MIB-1 positive cells. The tumor was then diagnosed as a pancreatic hamartoma.
Conclusion: Beside on the above findings, we suggest that the term “well-demarcated solid and cystic lesion with
chronological morphological changes” could be a clinical keyword to describe pancreatic hamartomas.
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Background
Pancreatic tumor-like cystic lesions are significantly less
common than solid lesions, and they account for less than
1 % of all pancreatic tumors [1]. Cystic tumors of the pan-
creas are categorized as pseudocysts and true lined cysts
(e.g., intraductal papillary mucinous neoplasm [IPMN],
mucinous cystic neoplasm [MCN], and serous cystic neo-
plasm [SCN]). Rare pancreatic cysts such as squamous-
lined cysts (e.g., lymphoepithelial cyst, epidermoid cyst, der-
moid cyst, and squamoid cyst) and solid-pseudopapillary
neoplasms (SPNs) have also been reported. In addition,
extremely rare non-neoplastic pancreatic tumors such
as hamartomas have been reported. The differential clin-
ical diagnosis of these pancreatic benign tumors from
malignant disease using abdominal ultrasound (AUS),
computed tomography (CT), magnetic resonance imaging
(MRI), endoscopic retrograde cholangiopancreatography
(ERCP), and endoscopic ultrasound (EUS) remains diffi-
cult despite advances in diagnostic imaging equipment [2].
Therefore, histological diagnosis with surgical resection is
often needed to diagnose these rare tumors. Here, we re-
port a case of pancreatic hamartoma and review the
English literature on this extremely rare pancreatic tumor.
Case presentation
A 68-year-old man presented with an asymptomatic
solid and multi-cystic mass in the uncus of the pancreas,
incidentally detected on abdominal enhanced CT during
a health examination. The patient had no relevant med-
ical history, including chronic pancreatitis. The tumor
was demonstrated to be a well demarcated solid and cystic
lesion, measuring 4.2 × 3.9 cm in diameter by enhanced
CT (Fig. 1a). The tumor consisted of a cystic lesion with
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iso- to low-density surrounded by an extremely low-
density area similar in density to adipose tissue. MRI and
magnetic resonance cholangiopancreatography (MRCP)
showed multilocular cysts ranging in size from one to sev-
eral millimeters in the pancreas uncus. The main pancre-
atic duct (MPD) showed no dilation and the evidence of
communications between the tumor and MPD was not
found (Fig. 2a). The morphological feature of the tumor
was completely different from pancreatic adenocarcinoma
and the tumor was initially diagnosed benign tumor such
as lipoma, dermoid cyst or the other rare benign tumor
(Table 1). During the first enhanced CT examination, the
patient developed an allergic reaction to contrast medium
so that the patient was followed-up regularly with plain
CT and MRI.
The patient visited for re-examination 21 months after
the initial visit because he had no symptoms. The size of
the pancreatic tumor had become smaller, measuring
3.9 cm in maximum diameter, and the internal structure
showed morphological changes with smaller cysts and a
larger solid lesion by plain CT (Fig. 1b) and MRI/MRCP
(Fig. 2b). The tumor displayed a honeycomb-like appear-
ance by EUS. At 28 months after the initial visit, the
tumor showed an increase in size by plain CT. MRCP
showed an increase in the size and number of the cysts,
with no infiltration into the pancreatic ducts (Figs. 1c
a b c
Fig. 1 Chronological changes seen on CT. a: First examination. The hypo-enhanced mass was 4.2 × 3.9 cm in size with solid and cystic lesions
located in the uncus of the pancreas. b: At 21 months after first examination. The tumor shown is 3.9 × 3.6 cm in size. The cystic lesion (yellow
arrow) had become smaller and the solid lesion (white arrow) had become larger. c: At 28 months after first examination. The tumor was 4.2 ×
3.3 cm in size. The cystic lesion changed and displayed irregular margins
a b c
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Fig. 2 a, b, c. Chronological changes seen on MRCP. a: At the first examination. The tumor was observed as multiple cystic lesions. b: At 21 months
after first examination. c: At 28 months after first examination. Figure 2-d, e, f, g. MRI appearance at 28 months after first examination. d: T1WI. A multi-
cystic lesion with low intensity was surrounded by a mass with iso-intensity. e: T2WI. A multi-cystic lesion displays low- to iso-intensity. The surrounding
tissue shows iso- to high intensity. f: T2-FAT-SAT. A multi-cystic high intensity lesion is shown. The surrounding tissue shows complete fat suppression.
g: T2WI (coronal image). A ringed multi-cystic lesion with high intensity is surrounded by a smooth superficial mass. A small nodule is seen inside of
the cyst ring
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and 2c). The multi-cystic lesion displayed low intensity
on T1-weighted imaging (T1WI), iso-intensity on T2-
weighted imaging (T2WI) and high intensity on T2-fat
saturation (FAT-SAT) by MRI. The solid lesion surround-
ing the multi cystic lesion displayed iso-intensity on
T1WI, iso- to high intensity on T2WI and low intensity
with complete fat-tissue suppression using T2-FATSAT
conditions (Fig. 2d-f). These findings demonstrated that
the cystic lesion consisted with pancreatic juice and the
solid lesion was a fat tissue.
On coronal T2WI imaging, ringed-multilocular cysts
with high intensity were surrounded by a smooth super-
ficial mass, and a small nodule was observed inside of
the cyst ring (Fig. 2g). These images suggested the possi-
bility of IPMN malignant transformation. At 31 months
after the initial diagnosis, the patient underwent surgical
resection. There were no symptoms or abnormal levels
of tumor markers (carcinoembryonic antigen [CEA], car-
bohydrate antigen 19-9 [CA19-9]) during follow-up.
Operative findings
A soft and elastic tumor was confirmed in the uncus of
the pancreas. The tumor was not exposed and there were
no inflammatory changes around the pancreas. Intraoper-
ative ultrasound showed a well demarcated honeycomb-
like cystic lesion in the pancreatic uncus, and there was
no evidence of venous or ductal invasion (Fig. 3). Pylorus
preserving pancreaticoduodenectomy was performed. The
operation was completed without any complications.
Macroscopic findings
A solid tumor consisting of yellow adipose tissue with a
smooth thin capsule measuring 40 × 40 × 28 mm in size
was confirmed in the pancreatic uncus. The inner structure
Table 1 Differential diagnosis of the rare cystic lesion of the pancreas




50s-60s Male Uni- or multilocular Serous to cheesy/caseous-appearing












20s-30s Female Tail Uni- or multilocular Serous to cheesy/casseous-appearing
depending on the degree of keratin
formation.
Lined by attenuated squamous
cells. Exist with accessory spleens.
High levels of CA 19-9 and/or CEA in




20s-30s Unknown Similar to the
teratoma
Cheesy or caseous, with
keratinaceous and sebaceous
secretions.
Skin appendages and sebaceous




Unknown Unknown Unilocular Acidophilic acinar Cystically dilated ducts lined by a
squamous/transitional epithelium.
Basal are positive for p63.
Superficial cells are positive for









Serous fluid Cuboidal glycogen-rich epithelial
cells positive for GLUT-1.
Sponge-like appearance Clear cytoplasm and well-defined
cytoplasmic borders. Small, round
nuclei with dense homogeneous
chromatin.
Von Hippel-Lindau gene is




(-30 to -120 HU)
and homogeneity
in enhanced CT
Mature adipose tissue, capsuled
by thin collagen layer




50s- 60s M:F=1.4:1 Head Solid and
cystic mass
Mature acini, ducts with
architectural disarrangement
surrounded by stromal fibrosis.
C34, CD117 or bcr-2 expression
for the stromal fibrosis.
Lack or decrease of islet cells. S-100 protein expression for
the ductal component.
CA19-9; Carbohydrate antigen 19-9, CEA: Carcinoembryonic antigen, GLUT-1: Glucose transporter -1
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of the tumor consisted of multiple cysts, and a white nod-
ule was found between the cysts (Fig. 4a).
Hematoxylin-eosin staining (HE)
The solid part of the mass consisted of mature adipose
tissue, and the cystic lesion consisted of colonization of
the dilated pancreatic ducts with mild fibrosis and infil-
tration of monocytes in the circumference. There was
no evidence of mucinous products in the cysts, and no
evidence of malignancy in the epithelial cells of the cysts.
A few normal scattered acini were observed in the solid
portion of the lesion, and the nodule located between
the cysts consisted of stromal fibrosis without atypical
cells (Fig. 4b).
Immunohistochemical staining (IHC)
The epithelial cells of the ducts expressed cytokeratin 7
and cytokeratin 19, but were negative for cytokeratin 20.
The adipose tissue was positive for S-100 protein, and
mostly negative for MIB-1 (Ki-67). These results suggest
that the tumor was non-proliferative (Fig. 5). Based on
these findings, the tumor was determined to be com-
posed of a mixture of differentiated cell types that are
normally present in the pancreas. It was therefore
regarded as a malformation rather than a neoplasm. Giv-
ing these findings, the tumor was diagnosed as a pancre-
atic hamartoma.
After surgical resection, the patient received follow-up
examination with plain CT every three to six months
and there was no recurrence for 50 months.
Discussion
Pancreatic hamartoma is an extremely rare benign dis-
ease of the pancreas. With the improvements in diag-
nostic imaging equipment over the last decade, it has
become increasingly common to discover rare pancreatic
tumors such as those listed above. Although these tu-
mors are usually not aggressive, they typically require
surgical resection because of the difficulty in prospective
clinical diagnosis [2]. Accurate knowledge about these
rare pancreatic tumors is therefore necessary. Table 1
shows the clinical features of the rare pancreatic tumors
for which differential diagnosis was carried out in the
present case [1, 3–31]. The information in Table 1 pro-
vides the clinical and histological characteristics of each
disease. However, this information alone is not sufficient
to be used as decisive diagnostic evidence.
Albrecht [32] first introduced the term “hamartoma”
to describe “tumor-like malformations” of the liver,
spleen, kidney, and breast that show an abnormal admix-
ture of normal components typical of the organ involved.
A hamartoma may be regarded as a malformation rather
than a neoplasm. A pancreatic hamartoma is an extremely
rare pancreatic tumor, accounting for < 1 % of occurrences
of tumor-like cystic lesions of the pancreas [15]. There are
only 30 cases of pancreatic hamartoma reported in the
English literature to date [3–20], including the first case
reported by Anthony et al. in 1977 [3]. All of these reports
have described the difficulty in imaging diagnosis, and al-
most all patients underwent surgical resection because of
the possibility of malignant disease.
Table 2 (Additional file 1 shows detailed data) shows
the clinical and pathological features of 31 cases of
pancreatic hamartoma, including the present case. The
median age of the patients was 50.4 years (range,
34 weeks to 78 years), and there were no significant
differences in the male-to-female ratio (1.4/1.0). Thir-
teen of the patients had no clinical symptoms, and the
other patients had non-typical symptoms such as
abdominal pain and weight loss. Noltenius et al. [33]
suggested a relationship between the pancreatic
hamartoma-like appearance and chronic pancreatitis in
a case study of Wernicke’s encephalopathy with alco-
holic pancreatitis. In this study, only 4 cases were com-
plicated by pancreatitis. On the other hand, many
authors, including Pauser et al. [10], suggested that
hamartoma should be distinguished from pancreatitis
because chronic pancreatitis may just mimic hamartoma
lesions, while lacking acinar cells.
Regarding the morphological features of these cases,
15 cases showed a solid pattern, and 14 cases showed
Fig. 3 Intraoperative ultrasound examination. A well-demarcated
honeycomb-like cystic lesion in the pancreatic uncus was found. There
was no evidence of venous or ductal invasion
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both a solid and cystic pattern (this was unknown in two
cases). A solitary tumor was observed in 22 patients, and
multiple tumors were found in 6 cases (this was unknown
in three cases). All cases showed a well-demarcated line
and non-invasive growth. The median size of the main
tumor was 4.4 cm (range, 0.9–19 cm). Twenty-one of the
reported hamartomas were located in the head, four were
located in the body, and 4 in the tail of the pancreas. Two
cases were identified as diffuse tumors.
There were only a few patients who could be followed
for a long period of time. In the present case, we were
able to follow the patient over 2 years, during which we
a
(HE x40) (HE x400)b c
Fig. 4 Macroscopic and pathological findings of the pancreatic hamartoma. a: Solid and cystic tumor in the pancreatic uncus with a smooth, thin
capsule. Cysts were surrounded by yellow adipose tissue and a white nodule was found between the cysts. b: The solid lesion filled with mature
adipose tissue. There was no evidence of mucinous products in the cysts and no evidence of malignancy in the epithelial cells of the cysts. c: The
cystic lesion consisted of dilated ducts. Fibrosis and infiltration of monocytes were observed around the cysts. There were a few normal acini in
the solid lesion, and the nodule located between the cysts consisted of stromal fibrosis without atypical cells
Cytokeratin 7 x400 Cytokeratin 19 x400 Cytokeratin20 x400
S100 x400 MIB-1 x400
Fig. 5 Immunohistochemical stains. The epithelial cells of the ducts expressed cytokeratin 7 and cytokeratin 19, but were negative for cytokeratin 20.
The adipose tissue was positive for S-100 protein and mostly negative for MIB-1
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observed chronological morphological changes in the
tumor. Sueyoshi et al. [14] reported transformation of
the main tumor from multiple large cysts to multiple
micro-cysts with solid components in two months. We
suggest that this type of chronological morphological
change is likely one of the clinical features of pancreatic
hamartoma.
Regarding the pathological findings, almost all cases
demonstrated disarranged acinar and ductal cells em-
bedded in the fibrous stroma. The solid lesion con-
sisted of fibrous and adipose tissue, and the cystic
lesion consisted of dilated ducts. The ducts varied in
size and were lined by columnar epithelium without
atypical cells. The acinar cells were well differentiated
without normal lobular structures. In contrast, normal
islets of Langerhans were confirmed in only 9 cases.
Pauser et al. [9, 10] and Yamaguchi et al. [19] defined
the criteria for the diagnosis of pancreatic hamartoma
as: (i) forming a well-demarcated mass, (ii) being com-
prised of mature acini and ducts with distorted architec-
ture, and (iii) lacking discrete islets of Langerhans. When
other case reports are taken into consideration, the pres-
ence or absence of the islet cells is still controversial.
In immunohistochemical studies, several authors re-
ported that the acinar cells of pancreatic hamartomas
were positive for exocrine markers (amylase and tryp-
sin), and that the ductal cells were positive for epithelial
markers (CAM5.2, AE1/AE3 and EMA) [7, 9, 11, 17],
similar to what is observed in a normal pancreas. In the
present case, cytokeratin 7 and cytokeratin 19, two typ-
ical epithelial markers, were expressed in the ductal
cells. Conversely, expression of cytokeratin 20, a marker
of colorectal and bile ductal epithelium, was negative.
Some studies have reported negative staining for S-100
protein, α-smooth muscle actin (α-SMA), desmin and
bcr-2 in the stroma cells [11, 15, 17]. In contrast, other
cases, including the present case, showed positive stain-
ing for S-100 protein in the mature adipose tissue and
ductal components [12, 19, 20].
Nagata et al. [11] reported that some of the disordered
acinar cells, ductal epithelium, and stromal cells ex-
pressed Ki-67. In contrast, Kim et al. [15] and the
present case demonstrated negative staining for MIB-1.
Recently, many authors have reported that stromal spin-
dle cells express CD34 and CD117 [9–11, 15, 17, 19, 20].
CD34 is a myeloid stem-cell marker and is thought to
play an important role in maintaining stromal integrity
and inhibiting tumor cell migration. CD117 is a trans-
membrane tyrosine kinase receptor for stem cell factors
and is encoded by the proto-oncogene c-kit [10]. As
mentioned above, the characteristics of pancreatic hamar-
toma are still unclear and controversial. This causes
preoperative diagnosis to be difficult, and histological
diagnosis with surgical resection is often needed. More re-
ports are necessary to clarify the clinicopathological fea-
tures of pancreatic hamartomas.
Conclusion
Pancreatic hamartoma is an extremely rare tumor of the
pancreas. Recently, this disease has become clearly rec-
ognized, the clinical imaging diagnosis remains some of
difficult. We suggest that the term “well-demarcated
solid and cystic lesion with chronological morphological
changes” could be a clinical keyword to describe pancre-
atic hamartomas.
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Table 2 A summary of the literature review of pancreatic
hamartoma







Clinical features Size Mean (range) 4.4 cm
















Immunostaining CD34 15 cases
CD117 9 cases
S-100 11 cases
CK 7/8/19 3 cases
bcr-2 3 cases
Ki-67 1 cases
*Lack of some cases were not demonstrated in this table
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